Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hao, Xue-Zhi
23025  Ergebnisse:
Personensuche X
?
1

Efficacy and safety of concomitant immunotherapy and denosu..:

Li, Hong-Shuai ; Lei, Si-Yu ; Li, Jun-Ling...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Afatinib and Dacomitinib Efficacy, Safety, Progression Patt..:

Li, Hong-Shuai ; Wang, Shou-Zheng ; Xu, Hai-Yan...
Cancers.  14 (2022)  21 - p. 5307 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adeno..:

Liu, Yu-Tao ; Hao, Xue-Zhi ; Liu, De-Ruo...
Cancer Management and Research.  12 (2020)  - p. 4633-4643 , 2020
Link: https://doi.org/10.2147/..
 
?
4

Apatinib, a novel VEGFR inhibitor plus docetaxel in advance..:

Duan, Jian-Chun ; Wang, Zhi-Jie ; Lin, Lin...
Investigational New Drugs.  37 (2019)  4 - p. 731-737 , 2019
Link: https://doi.org/10.1007/..
 
?
5

Depth of Response was Associated with Progression-Free Surv..:

Liu, Yu-Tao ; Zhang, Kai ; Li, Cheng-Cheng...
Journal of Cancer.  10 (2019)  21 - p. 5108-5113 , 2019
Link: https://doi.org/10.7150/..
 
?
6

The Molecular Detection and Clinical Significance of ALK Re..:

Zhang, Ning-Ning ; Liu, Yu-Tao ; Ma, Li...
PLoS ONE.  9 (2014)  1 - p. e84501 , 2014
Link: https://doi.org/10.1371/..
 
?
7

Immunohistochemistry reliably detects ALK rearrangements in..:

Han, Xiao-Hong ; Zhang, Ning-Ning ; Ma, Li...
Virchows Archiv.  463 (2013)  4 - p. 583-591 , 2013
Link: https://doi.org/10.1007/..
 
?
8

Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC..:

Zhang, Jinyao ; Wang, Yan ; Liu, Ziling...
Thoracic Cancer.  12 (2021)  24 - p. 3407-3415 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Efficacy and safety of concomitant immunotherapy and denosu..:

Li, Hong-Shuai ; Lei, Si-Yu ; Li, Jun-Ling...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464943/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Afatinib and Dacomitinib Efficacy, Safety, Progression Patt..:

Li, Hong-Shuai ; Wang, Shou-Zheng ; Xu, Hai-Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656097/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adeno..:

Liu, Yu-Tao ; Hao, Xue-Zhi ; Liu, De-Ruo...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CMAR.S240275.  , 2020
Link: https://www.dovepress.co..
 
?
12

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adeno..:

Liu, Yu-Tao ; Hao, Xue-Zhi ; Liu, De-Ruo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306474/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Depth of Response was Associated with Progression-Free Surv..:

Liu, Yu-Tao ; Zhang, Kai ; Li, Cheng-Cheng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775600/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

Survival of patients with advanced lung adenocarcinoma befo..:

Liu, Yu-Tao ; Hao, Xue-Zhi ; Li, Jun-Ling...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567010/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
15

Analysis of clinicopathological features of the echinoderm ..:

Liu, Yu-Tao ; Shi, Yuan-Kai ; Hao, Xue-Zhi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704311/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
1-15